Fluzone High-Dose Quadrivalent has been approved for use in patients over 65 to help prevent A and B strains of influenza.
Everyone over the age of six months and especially pregnant women are urged to get flu shots
Exciting and upcoming developments, years in the making.
H1N1 is the most prevalent flu virus circulating this year, resulting in a less severe flu season overall than last year when H3N2 was predominant.
A new report links early treatment of influenza A/H3N2 with the drug to a 30% decrease in mortality.
Researchers have found that the microbiome in the respiratory tract contributes to how susceptible we each are to the flu. Work is underway to use this data to create a preventive tool
A new study reveals that llama antibodies may be effective in offering protection against numerous flu strains in a single vaccine
A new poll suggests that misconceptions about the flu vaccine are at a three-year high, despite the fact that more patients seem to be receiving the vaccine. Find out what physicians can do to clear the air.
A new report highlights how flu vaccination rates decline as the day progresses, and how primary care practices can use ‘nudges’ to modify patient care behaviors.
A new vaccine in development could provide increased flu protection for seniors.